Mark Friedman of Arkansas Business reports
that Cantrell Pharmacy
, a drug compounding operation, has settled a complaint with the Food and Drug Administration
that will allow the company, which is reorganizing in bankruptcy, to stay open.
The FDA had tried to stop production
on account of shortcomings it found in sanitary
conditions in the drug-making process. The settlement allows Cantrell to stay open and calls for a re-inspection that Cantrell's owner says will show the company has been operating properly.